2022 annual financial data
Spyre Therapeutics 2022 Financial results
Direct answer
Revenue was 2,329,000 USD.
Operating income was -84,781,000 USD and net income was -83,815,000 USD.
Operating cash flow was -80,144,000 USD.
Get free Spyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,329,000 USD
- Operating income
- -84,781,000 USD
- Net income
- -83,815,000 USD
- Operating cash flow
- -80,144,000 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Spyre Therapeutics financial years